| DSM Biologics, a business unit
of DSM Pharmaceutical Products, is a global provider of manufacturing
technology & services to the biopharmaceutical industry. In addition
to offering world-class biopharmaceutical manufacturing services, DSM
Biologics has co-exclusive rights, along with Dutch biotech company
Crucell N.V., to license the high-producing PER.C6® human cell line as a
production platform for recombinant proteins and monoclonal antibodies.
DSM Biologics’ FDA-approved facility in Groningen, The Netherlands was
established in 1986, and has a strong track record in using a broad range
of cell lines (PER.C6®, CHO, hybridoma, etc.) in biopharmaceutical
manufacturing, and has wide-range of experience using multiple
manufacturing (batch, fed-batch and continuous perfusion) and purification
techniques. The combination of the PER.C6® human cell line and DSM’s
manufacturing services provides companies with a turn-key biologic
manufacturing solution reducing cost, risk and time to market. |
|
